Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannTrust Holdings Inc CNTTQ

CannTrust Holdings Inc is engaged in the business of producing and distributing medical cannabis in Canada. Its facility is located at Vaughan, Ontario in Canada. Its brands include LIIV, ESCAPE, SYNR.G and Peak Leaf.


GREY:CNTTQ - Post by User

Bullboard Posts
Post by gdown9on Oct 18, 2018 8:07am
84 Views
Post# 28825462

hidden gems - CannTrust

hidden gems - CannTrust
https://ca.proactiveinvestors.com/companies/news/204380/three-hidden-gems-stashed-away-in-a-cannabis-market-that-just-keeps-rolling-higher-204380.html

"

Uncovering hidden gems

“I would be more inclined to look at the mid-tier or select junior names at this time, since the Tier-1's are currently expensive," said Ben Smith, a research analyst and capital markets professional with Midas Letter, a business channel in the cannabis and cryptocurrency space. "In the mid-tier space, CannTrust Holdings Inc. (TSE:TRST) is a solid, profitable company with great management, brand, and growing medical enrollment patient base.

Smith believes the company could easily trade much higher if it uplists to an American exchange and captures US inflows.

CannTrust Holdings Inc is also a strong candidate to partner-up with Big Pharma, thus increasing shareholder value, he added.

"
Bullboard Posts